Salmonella enterica subsp. enterica

Global Typhoid Challenges in Focus at International Conference in Rwanda

Retrieved on: 
Tuesday, December 5, 2023
Drug resistance, Conference, Death, Internet, Research, Fever Dream, Sanitation, Urgency, Sabin Vaccine Institute, Drink, Education, Genetically modified bacteria, Coalition, WASH, Filtration, Climate change, Cat, Water, Weather, Food, Bill, Patient, Hygiene, Salmonella enterica subsp. enterica, Vaccine

KIGALI, Rwanda, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The 13th International Conference on Typhoid & Other Invasive Salmonelloses gets under way today in Kigali, Rwanda, with nearly 350 researchers, healthcare professionals and policymakers meeting to find ways to address the urgent challenges of typhoid and other invasive salmonelloses.

Key Points: 
  • KIGALI, Rwanda, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The 13th International Conference on Typhoid & Other Invasive Salmonelloses gets under way today in Kigali, Rwanda, with nearly 350 researchers, healthcare professionals and policymakers meeting to find ways to address the urgent challenges of typhoid and other invasive salmonelloses.
  • The three-day conference, hosted by the Coalition against Typhoid (CaT), housed at the Sabin Vaccine Institute, is the largest convening of the typhoid research community.
  • Typhoid is a bacterial infection contracted through the consumption of food or beverages contaminated with Salmonella Typhi.
  • There are an estimated 9-24 million cases of typhoid fever globally each year, leading to more than 110,000 deaths.

SK bioscience and Vaxxas Enter Joint Development Agreement for Needle-Free Patch Delivery of Typhoid Vaccine

Retrieved on: 
Thursday, August 24, 2023
MSD, Vaccine, Partnership, Joint, SK, Life, Typhoid fever, Vaccination, Diarrhea, Hilleman Laboratories, Biotechnology, Infection, IVI, Ministry of Food and Drug Safety, International Vaccine Institute, Fever Dream, World Health Organization, MFDS, Constipation, Research, Temperature, Abdominal pain, Science, Ministry, Salmonella enterica subsp. enterica, Risk, Water, Gavi, Nausea, Memorandum of understanding, Bill, Climate, Mortality, WHO, Health, Headache, Bill & Melinda Gates Foundation, Mental health, Safety, Skin, Fatigue, Disease, Pharmaceutical industry, Food, Wellcome, Rickettsia typhi

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement.

Key Points: 
  • SK bioscience and Vaxxas have officially entered into a Joint Development Agreement.
  • This collaboration is set to revolutionize vaccine delivery by developing a novel vaccine-delivery device combination product using Vaxxas' high-density microarray patch (HD-MAP) platform technology with SK bioscience's proprietary typhoid vaccine.
  • Under the agreement, SK bioscience will supply the antigen utilized by its typhoid conjugate vaccine, SKYTyhpoid™ that was jointly developed by SK bioscience and the International Vaccine Institute (IVI).
  • SK bioscience collaborated with Wellcome and the IVI on the development of a trivalent invasive non-typhoidal Salmonellosis vaccine candidate in 2019.

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch

Retrieved on: 
Thursday, August 24, 2023
Biotechnology, Health, Pharmaceutical, Other Philanthropy, Philanthropy, Other Science, Research, Medical Devices, Infectious Diseases, General Health, Foundation, Science, Clinical Trials, Medical Supplies, Vaccine, SK, Typhoid fever, Vaccination, International Vaccine Institute, Water quality, COVID-19, IVI, World Health Organization, Chickenpox, Shingles, Hygiene, Trial of the century, US, Salmonella enterica subsp. enterica, Risk, Water, Bill, WHO, Bill & Melinda Gates Foundation, Safety, Disease, Pharmaceutical industry, Wellcome, Rickettsia typhi, Food

The typhoid vaccine formulation used to coat the HD-MAP will be based on SKYTyhpoid™, an approved typhoid conjugate vaccine that was jointly developed by Vaxxas’ collaborator in this project, SK bioscience, and the International Vaccine Institute (IVI).

Key Points: 
  • The typhoid vaccine formulation used to coat the HD-MAP will be based on SKYTyhpoid™, an approved typhoid conjugate vaccine that was jointly developed by Vaxxas’ collaborator in this project, SK bioscience, and the International Vaccine Institute (IVI).
  • The typhoid vaccine product candidate used in these studies will be formulated to be more stable at higher temperatures than required for needle and syringe vaccination.
  • As such, success in this endeavor has the potential to increase global access to the life-saving typhoid vaccine.
  • This project continues to build on the progress of its HD-MAP technology in human clinical studies with other vaccine candidates including COVID-19 and influenza.

Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions

Retrieved on: 
Wednesday, February 15, 2023
EBS, Vaccine, Human, Emergent BioSolutions, Q&A, Investment, Viral disease, NYSE, Acquisition, EBITDA, Cooley, DKK, Extrapyramidal system, Food, Research, Salmonella enterica subsp. enterica, CET, USD, Marketing, Danske Bank, Disease, Morgan Stanley, FDA, Infection, EU, Typhoid fever, Prevalence, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, COVID-19, Cholera, OMX, Pharmaceutical industry, Fine chemical, Cryptocurrency, Bavarian Nordic, Chikungunya, Emergent, Nordea

A late-stage vaccine candidate targeting Chikungunya with expected Phase 3 read-out in the second half of 2023 and projected launch in 2025.

Key Points: 
  • A late-stage vaccine candidate targeting Chikungunya with expected Phase 3 read-out in the second half of 2023 and projected launch in 2025.
  • Travel vaccines are seeing a rebound after the COVID-19 pandemic and the expanded portfolio allows us to further explore synergies in our commercial presence across key markets.
  • There are currently no approved vaccines against Chikungunya, which analysts estimate could represent an annual market worth more than USD 500 million.
  • The management of Bavarian Nordic will host an investor/analyst call today, February 15, 2023, at 2 pm CET (8 am EST) to discuss the acquisition.

Pritzker Hageman Salmonella Lawyers File Lawsuit in 4th Outbreak at Great Moon Buffet in Saint Paul, Minnesota

Retrieved on: 
Thursday, January 12, 2023
Food safety, Salmonellosis, Minnesota Department of Health, Eating, Government, Salmonella enterica subsp. enterica, MDH, Minnesota Department of Human Rights, Restaurant, Salmonella

SAINT PAUL, Minn., Jan. 12, 2023 /PRNewswire/ -- The Pritzker Hageman Salmonella lawyers have filed a lawsuit (19HA-CV-23-161) arising from the fourth Salmonella Enteritidis outbreak linked to Great Moon Buffet in West Saint Paul.

Key Points: 
  • SAINT PAUL, Minn., Jan. 12, 2023 /PRNewswire/ -- The Pritzker Hageman Salmonella lawyers have filed a lawsuit (19HA-CV-23-161) arising from the fourth Salmonella Enteritidis outbreak linked to Great Moon Buffet in West Saint Paul.
  • Pritzker Hageman's legal team is representing a 34-year-old man hospitalized for a debilitating and painful Salmonella infection after eating at Great Moon Buffet in November 2021.
  • Despite repeated warnings from the Minnesota Department of Health (MDH), there have now been four known Salmonella outbreaks at Great Moon Buffet since 2018.
  • Pritzker Hageman's team of Salmonella lawyers has represented clients sickened in every major outbreak in the United States, including a lawsuit last year against Great Moon Buffet arising from the third outbreak.

Global Typhoid Fever Vaccines Market Report 2022: Increasing Government & NGO Initiatives to Raise Awareness Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 4, 2022
Infectious Diseases, Biotechnology, Pharmaceutical, Health, People, Vaccine, Ministry, Route of administration, Water, Typhoid fever, Immunity, Industry, List of health departments and ministries, WHO, CAGR, Drinking water, TCV, Time-invariant system, Region, Subclinical infection, Constipation, Headache, Croydon typhoid outbreak of 1937, Fever, Gavi, Partnership, Genetically modified bacteria, Salmonella, US, Mouth, Centers for Disease Control and Prevention, Center, Administration, Nausea, Organization, Marketing, Salmonella enterica subsp. enterica, Symptoms of COVID-19, Awareness

The "Typhoid Fever Vaccines Market, by Vaccine Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Typhoid Fever Vaccines Market, by Vaccine Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Typhoid fever is a bacterial infection caused by Salmonella typhi, which causes symptoms such as prolonged fever, headache, nausea, loss of appetite, and constipation or sometimes diarrhea.
  • Typhoid fever vaccines are the biological formulations, which provide immunity and protect an individual against typhoid fever.
  • Increasing initiatives by governments and various other organizations to increase awareness about typhoid vaccine and rising access of new vaccines is expected to drive the typhoid fever vaccines market growth during forecast period.

FERRERO VOLUNTARILY RECALLS KINDER® HAPPY MOMENTS CHOCOLATE ASSORTMENT AND KINDER® MIX CHOCOLATE TREATS BASKET BECAUSE OF POSSIBLE HEALTH RISK AND ADVISES CONSUMERS TO DISPOSE OF CERTAIN KINDER PRODUCTS NOT INTENDED FOR US DISTRIBUTION DUE TO RECALL OF

Retrieved on: 
Tuesday, April 12, 2022
Food and Drug Administration, Food safety, Food, Multimedia, Salmonella enterica subsp. enterica, Ferrero, Sale, Salmonella, Oil

The products are being recalled because they were manufactured in a facility where Salmonella Typhimurium was detected.

Key Points: 
  • The products are being recalled because they were manufactured in a facility where Salmonella Typhimurium was detected.
  • No other Kinder products distributed or sold by Ferrero U.S.A., Inc. are included in this recall.
  • Please dispose of it immediately, because the product could be included as part of a recall of certain Kinder products in Europe.
  • Consumers who have purchased the products mentioned above should not eat the product and may contact the Ferrero customer service line Monday - Friday 9am-6pm EST at 1-800-688-3552 or via https://www.ferreronorthamerica.com/contact-US-residents for product replacement.

FERRERO VOLUNTARILY RECALLS KINDER® HAPPY MOMENTS CHOCOLATE ASSORTMENT AND KINDER® MIX CHOCOLATE TREATS BASKET BECAUSE OF POSSIBLE HEALTH RISK

Retrieved on: 
Friday, April 8, 2022
Vomiting, Endocarditis, Ferrero, Diarrhea, Multimedia, Food and Drug Administration, Fever, Food safety, Salmonella enterica subsp. enterica, Kinder, Arthritis, Nausea, Food, Person, Salmonella, Abdominal pain, Infection, Vaccine, Motor vehicle, Online shopping

PARSIPPANY, N.J., April 7, 2022 /PRNewswire/ -- Ferrero U.S.A., Inc. of Parsippany, New Jersey is voluntarily recalling its Kinder Happy Moments Chocolate Assortment and Kinder Mix Chocolate Treats basket, because the product may be contaminated with Salmonella Typhimurium.

Key Points: 
  • PARSIPPANY, N.J., April 7, 2022 /PRNewswire/ -- Ferrero U.S.A., Inc. of Parsippany, New Jersey is voluntarily recalling its Kinder Happy Moments Chocolate Assortment and Kinder Mix Chocolate Treats basket, because the product may be contaminated with Salmonella Typhimurium.
  • Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
  • Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain.
  • The products are being recalled because they were manufactured in a facility where Salmonella typhimurium was detected.

Quadram Scientists Demonstrate Advantages of Fire Monkey HMW-DNA Extraction with Multiplexed Oxford Nanopore DNA Sequencing for Complete Hybrid Assemblies of Pathogen Genomes

Retrieved on: 
Tuesday, April 5, 2022
Biotechnology, Typhoid fever, Oxford Nanopore Technologies, HMW, Research, Abraxis BioScience, CSO, Reading, Technology, GSV, University of East Anglia, Security agency, Population, UK Health Security Agency, Bacteria, East Anglia, Conference, Molecular biology, Health, Gemma, Norfolk and Norwich University Hospitals NHS Foundation Trust, Super Mario, Microbiology, Orientation, Campylobacter, DNA, Merck Group, Gene expression, AMR, Biotechnology and Biological Sciences Research Council, Salmonella enterica subsp. enterica, Survival, Doctor of Philosophy, Genomics, Communication, Food chain, BBSRC, Partnership, Company, Cell, NAIP, Automation, Plant, UKHSA, Food, Biology, Microorganism, Norwich Research Park, R, Antibiotics, Vaccine, Fine chemical, Pharmaceutical industry, Purification, Quadram Institute, Tecan, Salmonella

LONDON, April 5, 2022 /PRNewswire/ -- UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), welcomes data presented by scientists from its collaborator the Quadram Institute at this years' Microbiology Society Annual Conference being held in Belfast. The Quadram's team results demonstrate the advantages of Fire Monkey high molecular weight (HMW) DNA extraction with multiplexed Oxford Nanopore sequencing for cost effective complete hybrid assemblies of pathogen genomes in resolving genomic rearrangements important in acute and chronic Salmonella infections.

Key Points: 
  • The Quadram's team results demonstrate the advantages of Fire Monkey high molecular weight (HMW) DNA extraction with multiplexed Oxford Nanopore sequencing for cost effective complete hybrid assemblies of pathogen genomes in resolving genomic rearrangements important in acute and chronic Salmonella infections.
  • Extraction of long length HMW DNA using RevoluGen's Fire Monkey technology facilitated 48-plex sequencing and the successful generation of complete assemblies for samples with ~30X theoretical coverage.
  • Fire Monkey produces DNA fragments that are not too short and not too long for the long-read sequencing technologies.
  • It also facilitates hybrid sequencing from a single extraction, saving valuable DNA samples as well as reducing time and cost.

Quadram Scientists Demonstrate Advantages of Fire Monkey HMW-DNA Extraction with Multiplexed Oxford Nanopore DNA Sequencing for Complete Hybrid Assemblies of Pathogen Genomes

Retrieved on: 
Tuesday, April 5, 2022
Biotechnology, Typhoid fever, Oxford Nanopore Technologies, HMW, Research, Abraxis BioScience, CSO, Reading, Technology, GSV, University of East Anglia, Security agency, Population, UK Health Security Agency, Bacteria, East Anglia, Conference, Molecular biology, Health, Gemma, Norfolk and Norwich University Hospitals NHS Foundation Trust, Super Mario, Microbiology, Orientation, Campylobacter, DNA, Merck Group, Gene expression, AMR, Biotechnology and Biological Sciences Research Council, Salmonella enterica subsp. enterica, Survival, Doctor of Philosophy, Genomics, Communication, Food chain, BBSRC, Partnership, Company, Cell, NAIP, Automation, Plant, UKHSA, Food, Biology, Microorganism, Norwich Research Park, R, Antibiotics, Vaccine, Fine chemical, Pharmaceutical industry, Purification, Quadram Institute, Tecan, Salmonella

LONDON, April 5, 2022 /PRNewswire/ -- UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), welcomes data presented by scientists from its collaborator the Quadram Institute at this years' Microbiology Society Annual Conference being held in Belfast. The Quadram's team results demonstrate the advantages of Fire Monkey high molecular weight (HMW) DNA extraction with multiplexed Oxford Nanopore sequencing for cost effective complete hybrid assemblies of pathogen genomes in resolving genomic rearrangements important in acute and chronic Salmonella infections.

Key Points: 
  • The Quadram's team results demonstrate the advantages of Fire Monkey high molecular weight (HMW) DNA extraction with multiplexed Oxford Nanopore sequencing for cost effective complete hybrid assemblies of pathogen genomes in resolving genomic rearrangements important in acute and chronic Salmonella infections.
  • Extraction of long length HMW DNA using RevoluGen's Fire Monkey technology facilitated 48-plex sequencing and the successful generation of complete assemblies for samples with ~30X theoretical coverage.
  • Fire Monkey produces DNA fragments that are not too short and not too long for the long-read sequencing technologies.
  • It also facilitates hybrid sequencing from a single extraction, saving valuable DNA samples as well as reducing time and cost.